Episode
Best of UEG Week - IBD with Bel Kok
- Podcast
- UEG Podcast
- Published
- Nov 4, 2025
- Duration seconds
- 1146
- Processing state
not_requested- Canonical source
- https://ueg-talks-podcast.podigee.io/61-new-episode
Actions
POST https://stenobird.com/v1/public/podcasts/ueg-podcast-6404464/episodes/best-of-ueg-week-ibd-with-bel-kok/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/ueg-podcast-6404464/best-of-ueg-week-ibd-with-bel-kok.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode of the UEG Podcast, our host Pradeep Mundre, together with IBD expert Klaartje Bel Kok, explore the latest breakthroughs in IBD presented at UEG Week 2025 in Berlin. From long-term IL-23 inhibitor data to novel drugs such as Obefazimod and Tulisokibart, the discussion covers key findings that are reshaping IBD management. Bel dives into new insights on JAK inhibitors in pregnancy, the growing role of ultrasound monitoring in IBD, and the challenge of choice overload in treatment decisions. Tune in for expert reflections on emerging research, collaboration within the IBD community, and the evolving understanding of IBD’s complex aetiology.